The science is hard to get one's head around for the average layperson imo -
CAP 1002 and ATL 1102 are two different therapies for Duchenne muscular dystrophy (DMD), a genetic disorder that causes progressive muscle loss and premature death. CAP 1002 is a cell therapy that uses donor heart cells to reduce inflammation and muscle degeneration12. ATL 1102 is an antisense inhibitor that targets a protein involved in the fibrotic process in DMD
Bottom line, I guess it will be a case of which therapy works best and who gets there first with runs on the board! - as we all know, there are no guarantees of success in the Biotech space with everyone competing to be first past the post - just maybe ATL1102 will deliver the goods this time around for all concerned!
GLTAH's
.
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-2412
-
- There are more pages in this discussion • 1,115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.001(1.22%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $20.79K | 256.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 119742 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 43738 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 119742 | 0.079 |
1 | 6500 | 0.078 |
2 | 121300 | 0.077 |
1 | 130000 | 0.076 |
4 | 273335 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 43738 | 2 |
0.083 | 214435 | 1 |
0.084 | 109832 | 2 |
0.085 | 4326 | 1 |
0.087 | 125000 | 1 |
Last trade - 11.48am 27/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |